Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

Nature Communications

Volumn 6, Issue , 2015, Pages

  Hong, Matthew K H ^a,b   Macintyre, Geoff ^a,c   Wedge, David C ^d   Van Loo, Peter ^d,e,f   Patel, Keval ^c   Lunke, Sebastian ^a   Alexandrov, Ludmil B ^d,g   Sloggett, Clare ^a   Cmero, Marek ^a,b   Marass, Francesco ^c   Tsui, Dana ^c   Mangiola, Stefano ^a   Lonie, Andrew ^a   Naeem, Haroon ^a   Sapre, Nikhil ^a,b   Phal, Pramit M ^h   Kurganovs, Natalie ^a,b   Chin, Xiaowen ^a,b   Kerger, Michael ^a,b   Warren, Anne Y ^c   Neal, David ^c   Gnanapragasam, Vincent ^c   Rosenfeld, Nitzan ^c   Pedersen, John S ^i,j   Ryan, Andrew ⁱ   Haviv, Izhak ^k   Costello, Anthony J ^a,b   Corcoran, Niall M ^a,b   Hovens, Christopher M ^a,b   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b EPWORTH HOSPITAL   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^g LOS ALAMOS NATIONAL LABORATORY   (United States)

^h ROYAL MELBOURNE HOSPITAL   (Australia)

ⁱ Tissupath Pty Ltd   (Australia)

^j MONASH UNIVERSITY   (Australia)

^k BAR ILAN UNIVERSITY   (Israel)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; MESSENGER RNA; TP53 PROTEIN, HUMAN;

BLOOD; CANCER; CLONE; GENOME; GERM CELL; MUTATION;

ARTICLE; BLOOD; CANCER RECURRENCE; CANCER STAGING; CELL CLONE; CONTROLLED STUDY; DISTANT METASTASIS; GENE DOSAGE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN GENOME; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIMARY TUMOR; PROSTATE CANCER; RNA SEQUENCE; TREATMENT RESPONSE; TUMOR BIOPSY; ADENOCARCINOMA; AGED; BONE TUMOR; BRAIN TUMOR; COPY NUMBER VARIATION; DISEASE COURSE; DNA SEQUENCE; GENETICS; LONGITUDINAL STUDY; MIDDLE AGED; MUTATION; PATHOLOGY; PROSTATE TUMOR; SECONDARY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; AGED; BONE NEOPLASMS; BRAIN NEOPLASMS; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84926330368     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7605     Document Type: Article

References (54)

1. Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214-220 (2011).
2. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22 (2010).
3. Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
4. Weischenfeldt, J. et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159-170 (2013).
5. Kumar, A. et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc. Natl Acad. Sci. USA 108, 17087-17092 (2011).
6. Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243 (2012).
7. Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666-677 (2013).
8. Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117 (2010).
9. Campbell, P. J. et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467, 1109-1113 (2010).
10. de Bruin, E. C. et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution. Science 346, 251-256 (2014).
11. Zhang, J. et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science 346, 256-259 (2014).
12. Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994-1007 (2012).
13. Karakiewicz, P. I. et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 66, 1245-1250 (2005).
14. Coopman, P. J. & Mueller, S. C. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett. 241, 159-173 (2006).
15. Dong, S. W. et al. Research on the reactivation of Syk expression caused by the inhibition of DNA promoter methylation in the lung cancer. Neoplasma 58, 89-95 (2011).
16. Ogane, S. et al. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma. Int. J. Cancer 124, 2651-2657 (2009).
17. Behjati, S. et al. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat. Genet. 46, 376-379 (2014).
18. Alexandrov, L. B. & Stratton, M. R. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr. Opin. Genet. Dev. 24, 52-60 (2014).
19. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
20. Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993 (2012).
21. Zhang, C. Z., Leibowitz, M. L. & Pellman, D. Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements. Genes Dev. 27, 2513-2530 (2013).
22. Shen, M. M. Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23, 567-569 (2013).
23. Briggs, S. & Tomlinson, I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J. Pathol. 230, 148-153 (2013).
24. Palles, C. et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45, 136-144 (2013).
25. Pritchard, C. C. et al. Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer. Nat. Commun. 5, 4988 (2014).
26. Forshew, T. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra168 (2012).
27. Carreira, S. et al. Tumor clone dynamics in lethal prostate cancer. Sci. Transl. Med. 6, 254ra125 (2014).
28. Lang, G. A. et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119, 861-872 (2004).
29. Olive, K. P. et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119, 847-860 (2004).
30. Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L. & Delia, D. P53 expression in breast cancer. Int. J. Cancer 41, 178-183 (1988).
31. Leroy, B., Anderson, M. & Soussi, T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Hum. Mutat. 35, 672-688 (2014).
32. Barbieri, C. E. & Tomlins, S. A. The prostate cancer genome: perspectives and potential. Urol. Oncol. 32, 53 e15-e22 (2014).
33. Barbieri, C. E. et al. The mutational landscape of prostate cancer. Eur. Urol. 64, 567-576 (2013).
34. Schoenborn, J. R., Nelson, P. & Fang, M. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification. Clin. Cancer Res. 19, 4058-4066 (2013).
35. Boyd, L. K., Mao, X. & Lu, Y. J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nat. Rev. Urol. 9, 652-664 (2012).
36. Yoshimoto, M. et al. PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade. Mod. Pathol. 26, 435-447 (2013).
37. Kim, T. M. et al. Regional biases in mutation screening due to intratumoral heterogeneity of prostate cancer. J. Pathol. 233, 425-435 (2014).
38. Hong, M. K. et al. Percutaneous image-guided biopsy of prostate cancer metastases yields samples suitable for genomics and personalised oncology. Clin. Exp. Metastasis 31, 159-167 (2014).
39. Larson, D. E. et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311-317 (2012).
40. NCBI Resource Coordinators. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 42, D7-D17 (2014).
41. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78-81 (2010).
42. Schroder, J. et al. Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads. Bioinformatics 30, 1064-1072 (2014).
43. Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910-16915 (2010).
44. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
45. Clarke, L. et al. The 1000 Genomes Project: data management and community access. Nat. Methods 9, 459-462 (2012).
46. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
47. Lohse, M. et al. RobiNA: a user-friendly, integrated software solution for RNA-Seq-based transcriptomics. Nucleic Acids Res. 40, W622-W627 (2012).
48. Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
49. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
50. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Rep. 3, 246-259 (2013).
51. Bolli, N. et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat. Commun. 5, 2997 (2014).
52. Futreal, P. A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
53. Tamborero, D. et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3, 2650 (2013).
54. Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).